98 related articles for article (PubMed ID: 12433592)
1. Sleep-wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat.
Mavanji V; Meti B; Datta S
Eur J Pharmacol; 2002 Nov; 455(1):35-41. PubMed ID: 12433592
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats.
Meert TF; Melis W; Aerts N; Clincke G
Behav Pharmacol; 1997 Aug; 8(4):353-63. PubMed ID: 9832994
[TBL] [Abstract][Full Text] [Related]
3. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
Kennett GA; Curzon G
Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
[TBL] [Abstract][Full Text] [Related]
4. Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression.
Mavanji V; Datta S
Neuroreport; 2002 Sep; 13(13):1603-6. PubMed ID: 12352610
[TBL] [Abstract][Full Text] [Related]
5. Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves.
Sanford LD; Ross RJ; Seggos AE; Morrison AR; Ball WA; Mann GL
Pharmacol Biochem Behav; 1994 Sep; 49(1):93-100. PubMed ID: 7816896
[TBL] [Abstract][Full Text] [Related]
6. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
[TBL] [Abstract][Full Text] [Related]
7. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
Ponzoni A; Monti JM; Jantos H
Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
[TBL] [Abstract][Full Text] [Related]
8. Central administration of mCPP, a serotonin 5-HT(2B/2C) agonist, decreases water intake in rats.
Castro L; Maldonado I; Campos I; Varjão B; Angelo AL; Athanazio RA; Barbetta MC; Ramos AC; Fregoneze JB; De Castro e Silva E
Pharmacol Biochem Behav; 2002 Jul; 72(4):891-8. PubMed ID: 12062579
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2003 Oct; 478(2-3):121-30. PubMed ID: 14575796
[TBL] [Abstract][Full Text] [Related]
10. Effects of mianserin on human sleep.
Maeda Y; Hayashi T; Furuta H; Kim Y; Morikawa K; Ishiguro N; Ueno K; Sano J; Yamaguchi N
Neuropsychobiology; 1990-1991; 24(4):198-204. PubMed ID: 2135711
[TBL] [Abstract][Full Text] [Related]
11. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
Kreiss DS; Coffman CF; Fiacco NR; Granger JC; Helton BM; Jackson JC; Kim LV; Mistry RS; Mizer TM; Palmer LV; Vacca JA; Winkler SS; Zimmer BA
Pharmacol Biochem Behav; 2013 Mar; 104():119-24. PubMed ID: 23333679
[TBL] [Abstract][Full Text] [Related]
12. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
[TBL] [Abstract][Full Text] [Related]
13. Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats.
Sood S; Morrison JL; Liu H; Horner RL
Am J Respir Crit Care Med; 2005 Nov; 172(10):1338-47. PubMed ID: 16020803
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
[TBL] [Abstract][Full Text] [Related]
15. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
[TBL] [Abstract][Full Text] [Related]
16. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.
Walker EA; Kohut SJ; Hass RW; Brown EK; Prabandham A; Lefever T
Neuropharmacology; 2005 Dec; 49(8):1210-9. PubMed ID: 16165167
[TBL] [Abstract][Full Text] [Related]
17. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
18. Effects of serotonin 1A agonist on acute spinal cord injury.
Saruhashi Y; Matsusue Y; Hukuda S
Spinal Cord; 2002 Oct; 40(10):519-23. PubMed ID: 12235534
[TBL] [Abstract][Full Text] [Related]
19. A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat.
Amici R; Sanford LD; Kearney K; McInerney B; Ross RJ; Horner RL; Morrison AR
Brain Res; 2004 Jan; 996(1):9-18. PubMed ID: 14670626
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.
Carley DW; Radulovacki M
Am J Respir Crit Care Med; 1999 Dec; 160(6):1824-9. PubMed ID: 10588592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
